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1,

Marked deﬁcits in glucose availability, or glucoprivation, elicit organism-wide counter-regulatory responses whose purpose is to restore glucose homeostasis. However, while catecholamine neurons of the ventrolateral medulla (VLMCA) are thought to orchestrate these
responses, the circuit and cellular mechanisms underlying speciﬁc counter-regulatory
responses are largely unknown. Here, we combined anatomical, imaging, optogenetic and
behavioral approaches to interrogate the circuit mechanisms by which VLMCA neurons
orchestrate glucoprivation-induced food seeking behavior. Using these approaches, we found
that VLMCA neurons form functional connections with nucleus accumbens (NAc)-projecting
neurons of the posterior portion of the paraventricular nucleus of the thalamus (pPVT).
Importantly, optogenetic manipulations revealed that while activation of VLMCA projections
to the pPVT was sufﬁcient to elicit robust feeding behavior in well fed mice, inhibition of
VLMCA–pPVT communication signiﬁcantly impaired glucoprivation-induced feeding while
leaving other major counterregulatory responses intact. Collectively our ﬁndings identify
the VLMCA–pPVT–NAc pathway as a previously-neglected node selectively controlling
glucoprivation-induced food seeking. Moreover, by identifying the ventrolateral medulla as a
direct source of metabolic information to the midline thalamus, our results support a growing
body of literature on the role of the PVT in homeostatic regulation.
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lucose is the main metabolic source of energy in the
bloodstream and as such its level is tightly regulated. To
ensure homeostatic control of this vital metabolite, large
decreases in glucose availability – termed glucoprivation – elicit
well-characterized counterregulatory responses (to reestablish
normal blood glucose levels) that include mobilization of stored
glucose, corticosterone secretion, and feeding behaviors1,2. Decades
of research have shown that this system-wide response to glucoprivation is coordinated by centrally organized neural mechanisms.
In particular, research indicates that catecholamine neurons of the
ventrolateral medulla (VLMCA) contribute to glucose counterregulatory responses3. Indeed, VLMCA neurons are rapidly activated following episodes of extreme glucose deﬁciency. In turn, the
VLMCA is thought to trigger complex autonomic, endocrine and
behavioral responses. Importantly, while both ascending and
descending projections of VLMCA neurons have been tied to
speciﬁc counterregulatory responses4,5, the precise downstream
neural circuits controlling these responses, and in particular
glucoprivation-induced feeding, remain unknown.
Results
VLMCA–pPVT connections are sufﬁcient to trigger food
seeking. To investigate putative circuits involved in glucoprivic
feeding, we ﬁrst examined the distribution of forebrain projections of VLMCA neurons. For this, we labeled synaptic terminals
arising from VLMCA neurons by injecting an adeno-associated
viral vector (AAV) expressing Synaptophysin-green ﬂuorescent
protein (Syp)-GFP in the VLM of TH-Cre mice, in which Cre
recombinase expression is under the control of the tyrosine
hydroxylase (TH) endogenous promoter6,7 (Fig. 1a). This strategy
allowed us to identify brain areas receiving synaptic inputs from
VLMCA neurons. Consistent with previous studies, we observed
that VLMCA neurons provide major synaptic input to multiple
TH-rich forebrain structures, including the paraventricular
nucleus of the hypothalamus, the bed nucleus of the stria terminalis, and the posterior portion of the paraventricular nucleus
of the thalamus (pPVT)8–10 (Fig. 1b, c). Of these projections we
focused our studies on the pPVT due to its strong innervation of

a

the nucleus accumbens (NAc), a structure well-known to have
major effects on reward behaviors including food seeking
(Fig. 1a–c)11,12.
Previous studies suggest that the PVT is a critical node linking
hypothalamic hunger signals to goal-directed seeking behavior via
projections to the ventral striatum11,13. However, whether the
relay of metabolic status to the PVT is limited to hypothalamic
input or may also occur through projections from hindbrain
regions remains unclear. Consistent with previous literature, a
recent study reported that chemogenetic activation of
glucoprivation-sensitive VLMCA neurons drives food intake in
well-fed mice6. While chemogenetic activation is a useful tool to
investigate the role of deﬁned neurons, it has poor temporal
resolution. Therefore, since VLMCA neurons send projection to
the pPVT, we sought to determine if these are required for foodseeking behavior by using optogenetics, which facilitates the
dissection of different neural outputs with improved spatial
resolution and temporal precision14. To accomplish this, we
injected into the VLM of TH-Cre mice a Cre-dependent AAVdriving expression of Channelrhodopsin-2 (ChR2) (or as control,
a ﬂuorescent reporter) and stimulated these speciﬁc projections
through an implanted optical ﬁber above the pPVT (Fig. 2a, b).
Surprisingly, short optogenetic stimulation of ChR2-expressing
VLMCA–pPVT terminals was sufﬁcient to drive robust feeding in
well-fed mice (Fig. 2c–e and Supplementary Movie 1). As
expected, this behavioral phenotype was strictly associated with
ChR2 expression because light-evoked feeding was absent in
control subjects (Fig. 2f, g). These data suggest that a pPVT
downstream circuit may be part of a speciﬁc VLM-mediated
response pathway.
While our ﬁnding that the pPVT is involved in food seeking is
consistent with recent publications11,15, activity in the pPVT has
also been linked to the emergence of negative emotional states
such as anxiety and aversion16. Thus, to investigate whether
VLMCA–pPVT projections might also impact these processes,
we assayed mice where we stimulated VLM-projections in the
elevated zero maze (EZM), the open ﬁeld test (OFT), and the realtime place preference (RTPP) assay (Supplementary Fig. 1).
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Fig. 1 Axonal projections from VLMCA neurons innervate the pPVT. a Schematic of virus injections strategy used to examine putative forebrain areas that
had robust axonal inputs of VLMCA neurons and that project to the NAc. b Representative images of a sagittal brain slice showing the distribution of
VLMCA projections, NAc-projecting neurons (Retro-tdTomato) and TH immunoreactivity (anti-TH) across various forebrain regions. c Representative
images showing magniﬁcations of the areas depicted in b, namely the pPVT (1), the aPVT (2), and the BNST/PVH region (3). White arrows depict regions
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Fig. 2 Optogenetic stimulation of the VLMCA terminals in the pPVT results in robust feeding behavior in well-fed mice. a Schematic of ChR2-expressing
and control viral vector injections, as well as optical ﬁber implantation for optogenetic activation VLMCA ﬁbers in the pPVT. b Representative image of
ChR2 expression in the VLM of TH-IRES-Cre mice and ChR2-labeled terminals in the pPVT. c Schematic of the experimental design and the stimulation
protocol used to measure feeding behavior during optogenetic stimulation of VLM terminals in the pPVT. Food intake was quantiﬁed in well-fed mice prior
to, during, and after light stimulation (30 min, pre-test, stimulation, and post-test). The stimulation protocol consisted of 30 min in which light stimulation
alternated between 1 min “light ON” (20 Hz) and 2 min “light OFF” bouts. d Plot of individual performance on feeding behavior during the pre-test,
stimulation, and post-test for ChR2 (VLM-ChR2) mice. e Quantiﬁcation of feeding behavior during VLMCA–pPVT stimulation for ChR2 mice. Total food
intake in grams, ChR2: Pre-Test, 0.116 ± 0.07; Stimulation, 0.430 ± 0.11; Post-Test, 0.115 ± 0.05, n = 12 mice; F(2,33) = 5.12, one-way ANOVA followed by
Tukey’s test. Group comparisons: Pre-Test vs Stimulation, *P = 0.02; Post-Test vs Stimulation, *P = 0.02. f Plot of individual performance on feeding
behavior during the pre-test, stimulation, and post-test for control (VLM-tdT) mice. g Quantiﬁcation of feeding behavior during VLMCA–pPVT stimulation
for control mice. Total food intake in grams, Control: Pre-Test, 0.002 ± 0.01; Stimulation, 0.012 ± 0.03; Post-Test, 0.012 ± 0.02, n = 10 mice; F(2,27) =
1.04, one-way ANOVA followed by Tukey’s test. Group comparisons: Pre-Test vs Stimulation, P = 0.44; Post-Test vs Stimulation, P = 1. Box chart legend:
box is deﬁned by 25th, 75th percentiles, whiskers are determined by 5th and 95th percentiles, and mean is depicted by the square symbol. Data presented
as mean ± SEM.

Results of these experiments showed that the VLMCA–pPVT
pathway was associated with decreased exploration of the open
segments of the EZM, consistent with an anxiogenic role of this
projection (Supplementary Fig. 1a–c). Anxiogenic effects were not
as apparent in the OFT, where instead a signiﬁcant reduction in
total distance traveled was observed (Supplementary Fig. 1d–g).
Finally, optogenetic stimulation did not alter time spent in the
stimulated side in RTPP assays (Supplementary Fig. 1h–k).
However, a similar reduction in locomotor activity, as seen in the
OFT, was observed in this task (Supplementary Fig. 1k). These
results indicate that while stimulation of VLMCA–pPVT projections does not causes aversion, activity in this pathway is
associated with increased anxiety and reduced exploratory
behavior17. Altogether, our ﬁndings suggest that VLMCA
projections to the pPVT drive robust feeding behavior in mice,
with moderate effects on affect.
pPVT–NAc projecting neurons are activated by VLMCA input.
Anatomical studies have found that most neurons of the pPVT
innervate the NAc18. In addition, recent studies implicate
PVT–NAc connectivity in reward-related behaviors in
rodents11,12,19. Based on these ﬁndings, we hypothesized that
VLMCA neurons promote feeding behavior by modulating the
activity of pPVT neurons projecting to the NAc. To test this
prediction, we ﬁrst examined whether VLMCA neurons form
anatomical connections with NAc-projecting neurons of the
pPVT using monosynaptic tracing20. With this approach, we

found that TH-expressing VLM neurons monosynaptically
innervate NAc-projecting PVT neurons (Supplementary Fig. 2).
Next, to probe whether VLMCA projections form functional
connections onto PVT–NAc neurons, we optogenetically stimulated VLMCA–PVT projections (using a red-shifted ChR2 variant;
ChrimsonR) and imaged calcium responses in NAc-projecting
pPVT neurons using ﬁber photometry in awake animals
(Fig. 3a–c). To achieve selective expression of the genetically
encoded calcium sensor GCaMP6s in NAc-projecting neurons of
the pPVT, we injected a viral vector that drives retrograde
expression of Cre recombinase (AAV(retro)-CAG-Cre) bilaterally
in the NAc of TH-Cre mice and subsequently a vector encoding
Cre-dependent GCaMP6s in the pPVT. Interestingly, we
observed that optogenetic activation of VLMCA input signiﬁcantly increased the ﬂuorescence of the genetically encoded
calcium sensor GCaMP6s in NAc-projecting pPVT neurons
(Fig. 3d–g). Notably, this effect was dependent on VLMCA neuron expression of ChrimsonR (Fig. 3f, g).
It is important to highlight that a limitation of this approach is
the possibility that delivering AAV(retro)-CAG-Cre in the NAc
might result in unwanted expression of Cre recombinase in nonTH neurons of the VLM of TH-Cre mice. Thus, while to the best
of our knowledge a functional VLM input to the NAc has not
been described in the literature, we conducted a variation of our
initial approach wherein expression of GCaMP6s depended
instead on Flp-mediated recombination (Supplementary Fig. 3).
Using this alternative strategy, we conﬁrmed that stimulation of
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Fig. 3 Photostimulation of VLMCA axonal inputs to pPVT increases the activity of pPVT–NAc neurons. a Schematic of the viral vector strategy and
optical ﬁber placement used for selectively expressing GCaMP6s in NAc-projecting neurons of the pPVT and red-shifted channelrhodopsin-2 (ChrimsonRtdTomato) in catecholaminergic neurons of the VLM of TH-IRES-Cre mice. b Representative images from a TH-IRES-Cre mouse expressing ChrimsonRtdTomato in the VLM. c Representative images of the pPVT showing axonal projections from the VLM (ChrimsonR-tdTomato; left), GCaMP6s expression
in pPVT–NAc neurons (middle), and overlay image showing colocalization between the projections from ChrimsonR-expressing VLM neurons and
GCaMP6s-expressing pPVT–NAc neurons (right). d Average GCaMP6s responses from pPVT–NAc neurons in ChrimsonR-expressing (purple) and
tdTomato-expressing (black) animals subjected to light stimulation. e Quantiﬁcation of food intake during VLMCA–pPVT stimulation for both ChrimsonR
and tdTomato showing increases in feeding after stimulation in well-fed ChrimsonR expressing mice. Total food intake in grams, ChrimsonR, 0.23 ± 0.05,
n = 9 mice; tdTomato, 0.03 ± 0.01, n = 6 mice; two-sided Unpaired t-test, **P = 0.006. f Heatmap showing individual trial GCaMP6s responses to light
stimulation (561 nm at 20 Hz) from both ChrimsonR-expressing and tdTomato-expressing (control) mice. g Left: Quantiﬁcation of light-evoked changes in
GCaMP6s ﬂuorescence in pPVT–NAc neurons from mice expressing ChrimsonR in VLMCA neurons. Area under the curve (AUC), Baseline, −0.21 ± 0.11;
Light ON, 190.65 ± 63.27; two-sided Paired t-test, **P = 0.008. Right: Quantiﬁcation of light-evoked changes in GCaMP6s ﬂuorescence in pPVT–NAc
neurons from mice expressing tdTomato in VLMCA neurons. Area under the curve (AUC), Baseline, 1.78 ± 1.83; Light ON, −23.13 ± 99.86; two-sided Paired
t-test, P = 0.79. Box chart legend: box is deﬁned by 25th, 75th percentiles, whiskers are determined by 5th and 95th percentiles, and mean is depicted by
the square symbol. Data presented as mean ± SEM.

VLMCA inputs to the pPVT leads to signiﬁcant increases in
GCaMP6s ﬂuorescence (Supplementary Fig. 3a–d) and drives
robust feeding behavior (Supplementary Fig. 3e). Collectively,
these ﬁndings demonstrate that activation of the VLMCA–pPVT
pathway is associated with increases in pPVT neuronal activity
and a robust feeding phenotype.
We employed two further strategies to obtain evidence
supporting this VLMCA–pPVT–NAc circuit. First, using chemogenetics, we found that stimulation of VLMCA neurons markedly
increased the expression of the immediate early gene cFos in
4

pPVT neurons (Supplementary Fig. 4). Second, we performed
in vitro whole-cell patch-clamp recordings from unidentiﬁed
neurons of the pPVT – since most pPVT neurons project to the
NAc18 – and stimulated ChR2-expressing terminals from VLMCA
neurons in this region. We observed that optogenetic stimulation
of VLMCA afferents leads to small but reproducible depolarizations in a large fraction of pPVT neurons (Supplementary Fig. 5).
Importantly, this effect was prevented by bath application of the
beta-adrenergic receptor blocker propranolol, consistent with the
adrenergic nature of VLMCA projections21,22. In summary, these
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results lend further support to the idea that VLMCA projections
excite pPVT–NAc neurons.
Our observation that VLMCA–pPVT projections, which
promote feeding in well-fed mice, excite pPVT–NAc neurons is
at odds with some studies linking PVT function to the
consumption of natural rewards. Indeed, previous reports have
linked feeding behavior with inhibitory modulation of the PVT
and the PVT–NAc pathway23–26. However, others have shown
that hunger signals and food seeking are associated with increases
in the activity of PVT neurons19,27–29. One interpretation that
may reconcile these seemingly contradictory results is that PVT
neurons play dissociable roles in food seeking and consummatory
behaviors through their NAc projections, such that increases in
PVT–NAc activity promote food-seeking behavior, while
decreases in neuronal activity result in consummatory behavior.
This idea is partially supported by a recent report showing that
optogenetic stimulation of a subpopulation of NAc-projecting
PVT neurons promotes food-seeking behavior19, and by the
observation that reward consumption is associated with inhibition of PVT–NAc projections11,26. Collectively, these studies
support the idea that bidirectional modulation of PVT circuits
coordinates reward seeking and consummatory (feeding) behaviors. However, because this model has not been formally tested,
we sought to investigate the dynamics of pPVT–NAc neuronal
activity during both the approach and consummatory phases of a
reward foraging decision task (Fig. 4). Speciﬁcally, mice were
trained to navigate a linear track in which visiting a “trigger-zone”
located on one end of the track enabled access to a reward on the
opposite end (“reward-zone”) (Fig. 4b). For each trial, reward
availability was signaled via a 1 s 8 KHz tone presented when
subjects remained on the “trigger-zone” for a least 2 s. Mice
readily learned to perform this task, as exempliﬁed by their ability
to complete 40–50 trials per session by the end of training. Next,
using ﬁber photometry we assessed the responses of pPVT–NAc
neurons during both reward approach (as a measurement of
food-seeking behavior) and consumption (see Methods). Consistent with the above model, we observed that while reward
approach was associated with a prominent increase in GCaMP6s
ﬂuorescence in pPVT–NAc neurons, reward access and consumption were largely associated with an abrupt decrease in
ﬂuorescence (Fig. 4c–h). Collectively, these results demonstrate
that the pPVT–NAc pathway is bidirectionally modulated by
reward seeking and consumption.
To investigate whether similar dynamics of pPVT–NAc neuronal
activity follows VLMCA-mediated activation of this circuit, we
contrasted the effects of light stimulation with those of subsequent
feeding events. Speciﬁcally, we analyzed changes in the GCaMP6s
ﬂuorescence of pPVT–NAc neurons following the retrieval of
individual food pellets (see Methods) from an automated food
dispenser30. This analysis revealed that while activation of VLMCA
projections led to short latency increases in neuronal activity in the
pPVT, feeding itself was associated to marked reductions in
GCaMP6s ﬂuorescence (Fig. 5 and Supplementary Figs. 3f–h and
6). Importantly, these food-associated attenuations in calcium
signals were distinct and temporally dissociated from those induced
by the cessation of light stimulation (Supplementary Fig. 7). In
summary, our ﬁndings are consistent with a model wherein
activation of pPVT–NAc neurons by VLMCA projections drives
food seeking, but subsequent feeding attenuates activity in this
pathway. Interestingly, light-induced excitation of pPVT–NAc
neurons was signiﬁcantly greater in sessions in which access to
food was prevented during the test (Supplementary Fig. 7).
Considering the anxiogenic and aversive effects associated with
activation of the pPVT, these ﬁndings suggest that activation of
VLMCA projections to the pPVT may drive food seeking through
negative reinforcement.

ARTICLE

The VLMCA–pPVT–NAc circuit is required for glucoprivationinduced food seeking. Given the known role of VLMCA neurons
in glucoprivation-mediated feeding behavior, we sought to
determine whether VLMCA–pPVT communication was involved
in this process. For this, we used the glucose analogue 2-deoxy-Dglucose (2DG) – which inhibits glycolysis – to produce a model of
glucoprivic feeding (Supplementary Fig. 8). Consistent with previous studies2, intraperitoneal (i.p.) injections of 2DG led to a
robust increase in cFos immunoreactivity in VLMCA neurons
(Supplementary Fig. 9). Notably, this manipulation led to similar
increases in cFos expression in the pPVT (Supplementary Fig. 9).
Next, to investigate whether the 2DG-mediated increase in cFos
expression in the pPVT depended on VLMCA neuronal activity,
we chemogenetically silenced VLMCA neurons with an inhibitory
designer receptor exclusively activated by designer drug
(DREADD), during glucoprivation (Fig. 6a, b). As predicted, i.p.
injection of the DREADD ligand clozapine-N-oxide (CNO) prior
to 2DG administration signiﬁcantly attenuated cFos expression in
the pPVT when compared to saline-injected controls (Fig. 6c, d).
These effects were not observed in mice in which VLMCA neurons were infected with control AAV (Fig. 6c, d). Together, these
results demonstrate that glucoprivation-associated activation of
pPVT neurons requires VLMCA input. A corollary of this ﬁnding
is that glucoprivation (2DG)-induced feeding should require
activation of the VLMCA–pPVT pathway. To verify this, we
optogenetically silenced VLMCA inputs to the pPVT immediately
following 2DG administration using the light gated chloride ionpump, eNpHR (halorhodopsin) (Fig. 7a, b). Congruent with our
proposition, silencing VLMCA–pPVT projections signiﬁcantly
attenuated 2DG-induced increases in feeding behavior (Fig. 7c).
Notably, optogenetic silencing of VLMCA axons to the pPVT had
no effect on 2DG-mediated adrenal medullary hyperglycemia or
increases in corticosterone secretion (Fig. 7d, e). These ﬁndings
lend empirical support to the idea that functional segregation
exists across the various projections of VLMCA neurons2. In
addition, we did not observe any effect of optogenetically silencing VLMCA–pPVT projections on feeding behavior elicited by
acute food restriction in the absence of 2DG (Fig. 7f), further
highlighting that this circuit is speciﬁcally engaged during glucoprivic events and is not involved in regulating normal food
intake associated with acute food restriction31.
Lastly, we examined whether the pPVT–NAc pathway is
necessary for glucoprivic feeding. For this, we chemogenetically
silenced pPVT–NAc projecting neurons using the inhibitory
DREADD (Fig. 8a, b). Our results showed that chemogenetic
inhibition of pPVT–NAc projecting neurons prior to 2DG
administration markedly attenuated 2DG-induced feeding in
DREADD-expressing mice (Fig. 8c). These ﬁndings underscore
the importance of pPVT–NAc pathway activation during foodseeking behavior.
Discussion
Here we have deﬁned a previously neglected VLMCA–pPVT–NAc
circuit that supports and mimics glucoprivation-induced feeding
behavior (Supplementary Fig. 10). Our identiﬁcation of this circuit provides a novel target for the pathogenesis of hypoglycemiaassociated autonomic failure (HAAF), a potentially lethal condition marked by an inability to detect ensuing glucoprivic episodes. Notably, our ﬁndings are in stark contrast with a recent
report suggesting that hypothalamic projections of catecholaminergic neurons of the nucleus of the solitary tract, which neighbors the VLM, guide glucoprivic feeding32. While the nature of
this discrepancy is unclear, it is important to mention that
whereas most studies on glucose counterregulatory mechanisms
attribute glucoprivation-induced feeding to the function of
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VLMCA neurons2, the NTS has been primarily reported to promote anorexinergic responses33–36.
While these ﬁndings coincide with previous studies highlighting a role for the PVT in both aversive and reward-related
behaviors11,16,19,37–44, the complex nature of the behavioral
phenotype elicited by the activation of VLMCA–pPVT projections
warrant further discussion. Notably, whereas optogenetic stimulation of this pathway acutely decreases exploratory behavior
and increases anxiety, feeding behavior emerges shortly after the
offset of light stimulation (Supplementary Fig. 6; Supplementary
Movie 1). One potential interpretation to these seemingly
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contradicting behavioral outcomes is that activation of
VLMCA–pPVT projections mimics the debilitating and aversive
effects of hypoglycemic state45–47. Indeed, previous studies have
shown that VLMCA neurons, which encompass the noradrenergic
(A1) and adrenergic (C1) cell groups2, are activated by potentially
life-threatening situations such as hypoxia and hypoglycemia3,48
suggesting that their recruitment promotes aversive states49.
In addition, administration of 2DG to induce hypoglycemia
has been shown to49,50 drive decreased locomotion and to
promote negative affective states, thereby resembling the effects of
VLMCA–pPVT stimulation. Within this context, VLMCA neurons
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Fig. 4 The activity of pPVT–NAc neurons increases during food-seeking behavior in hungry mice and decreases during feeding. a Schematic of the viral
vector strategy and optical ﬁber placement used for selectively expressing GCaMP6s in NAc-projecting neurons of the pPVT. b Schematics of the reward
foraging task. To initiate a trial, mice awaited in the trigger zone for an auditory cue (8 KHz, 1 s) which signaled reward availability. Mice then ran to the
reward zone to retrieve a liquid food reward. c Heatmap of GCaMP6s responses from pPVT–NAc neurons during performance of individual trials of the
foraging task. GCaMP6s responses were time-locked to cue onset and trials were sorted by latency to complete a trial. Yellow dots represent ﬁrst nosepoke into the food-port. d Average GCaMP6s responses from pPVT–NAc neurons during the foraging task. Gray bar indicates the delivery of auditory cue
during trial initiation. Trial inclusion criteria was set to trials performed under 10 s noted by the red dotted line. e Quantiﬁcation of the changes in GCaMP6s
ﬂuorescence in pPVT–NAc neurons during the onset of trial performance in the foraging task. AUC, Baseline, −0.05 ± 0.02; Approach, 17.58 ± 5.87; n = 5
mice, two-sided Paired t-test, *P = 0.04. f Heatmap of GCaMP6s responses from pPVT–NAc neurons during feeding bouts in the foraging task. GCaMP6s
responses were time-locked to ﬁrst nose-poke into the food-port. g Average GCaMP6s responses from pPVT–NAc neurons during feeding bouts in the
foraging task. Gray line signals ﬁrst nose-poke into the food-port. h Quantiﬁcation of the changes in GCaMP6s ﬂuorescence in pPVT–NAc neurons during
the onset of feeding in the foraging task. AUC, Baseline, 0.52 ± 0.31; Approach, −18.08 ± 2.91; n = 4 mice, two-sided Paired t-test, **P = 0.008. Box chart
legend: box is deﬁned by 25th, 75th percentiles, whiskers are determined by 5th and 95th percentiles, and mean is depicted by the square symbol. Data
presented as mean ± SEM.
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Fig. 5 Feeding behavior is associated with decreases in GCaMP6s ﬂuorescence in pPVT–NAc neurons. a Representative trace showing the effect of light
stimulation (blue lines) on GCaMP6s ﬂuorescence of pPVT–NAc neurons (black line). Notice that initiation of food intake (red lines) was immediately
followed by decreases in the ﬂuorescence of the GCaMP6s signal (depicted with black arrowheads). b Average GCaMP6s response from pPVT–NAc
neurons following the onset of a feeding bout (illustrated by the black arrow). c Heatmap of individual trials GCaMP6s responses to the initiation of feeding
bouts from ChrimsonR-expressing mice. d Quantiﬁcation of feeding bouts onset changes in GCaMP6s ﬂuorescence in pPVT–NAc neurons. AUC, Baseline,
−0.47 ± 0.38; Feeding bout, –77.48 ± 35.16; n = 7 mice, two-sided Paired t-test, P = 0.052. Box chart legend: box is deﬁned by 25th, 75th percentiles,
whiskers are determined by 5th and 95th percentiles, and mean is depicted by the square symbol. Data presented as mean ± SEM.

may relay hypoglycemia-related aversive signals to the pPVT to
promote food-seeking behavior. This notion is consistent with
extensive literature demonstrating that the PVT is sensitive to
aversive stimuli and participates in regulating adaptive
behaviors16,51. Moreover, our results resemble recent observations linking the aversive elements of drug withdrawal to
increased PVT–NAc activity and subsequent drug-seeking
behavior40. Indeed, here we have included novel evidence
demonstrating that while food-seeking behavior is associated with
the activation of PVT–NAc projections, subsequent reward
consumption results in inhibition of this pathway (Fig. 4). The
latter observation is consistent with a recent report showing that
non-appetitive rewarding stimuli attenuate PVT neuronal

activity52. Collectively, these ﬁndings raise the possibility that the
PVT drives goal-directed behavior through negative reinforcement. Indeed, while not directly assessed in the present study, our
observation that the activational effects of VLMCA–pPVT stimulation are potentiated when animals do not have access to food
is consistent with this model (Supplementary Fig. 7).
It is important to consider that since ﬁber-based photometric
signals represent the collective activity of a group of cells (in this
case NAc projecting pPVT neurons), it is possible that
pPVT–NAc neurons driving food seeking could be distinct from
those modulated by food consumption. Similarly, PVT neurons
promoting reward-related behaviors may be distinct from those
that participate in the orchestration of defensive behaviors37,38.
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Fig. 6 VLMCA neurons mediate glucoprivation-induced activation of the pPVT. a Schematic of the stereotaxic injections for selective expression of
DREADDi (hM4Di-mCherry) in VLMCA neurons of TH-IRES-Cre mice. b Representative images of the VLM from a TH-IRES-Cre mouse expressing the
hM4Di-mCherry virus. c Representative images showing cFos immunohistochemistry in the pPVT of mice expressing either the hM4Di-mCherry (left)
or tdTomato control virus (right) in the VLMCA and injected with either saline (top) or with CNO (bottom), 30 min before administration of 2DG.
d Quantiﬁcation of cFos immunoreactivity in PVT as cells/mm2, tdT-Saline, 698.85 ± 46.88, n = 6 mice; tdT-CNO, 619.06 ± 51.00, n = 6 mice; hM4DiSaline, 603.80 ± 53.13, n = 6 mice; hM4Di-CNO, 229.65 ± 46.19, n = 6 mice; effect of treatments, F(1,17) = 19.70, P < 0.001; effect of virus, F(1,17) = 22.43,
P < 0.001; interaction, F(1,17) = 8.28, P < 0.05, two-way analysis of variance (ANOVA) followed by Tukey’s test. Group comparisons: tdT_Saline vs
hM4Di_CNO, ***P = 0.00004, tdT_CNO vs hM4Di_CNO, ***P = 0.0002, hM4Di_Saline vs hM4Di_CNO, ***P = 0.0002. Data from Supplementary Fig. 4
included for comparison purposes (shaded portion of the graph). Box chart legend: box is deﬁned by 25th, 75th percentiles, whiskers are determined by 5th
and 95th percentiles, and mean is depicted by the square symbol. Data presented as mean ± SEM.

Thus, as recently proposed, future studies should aim to determine how functionally dissociable PVT neuronal subclasses are53.
Indeed, functionally distinct cell types have been recently
described in the PVT52.
A growing body of literature supports the idea that the PVT is an
important regulator of reward-related behaviors11,12,23,27,39,40,54.
Interestingly, PVT’s role in reward seeking appears to be under the
control of a wide range of afferent pathways55. While the precise
contributions of these PVT afferent inputs to the regulation of
appetitive behaviors have not been fully elucidated, current evidence suggest distinct roles of these inputs. The presence of such
distinct inputs coincides with an emerging view of the PVT as a
major hub for interoceptive and exteroceptive information
integration16,56. As such, whereas input from the prefrontal cortex
appears to relay information about learned associations to the PVT
(e.g., reward predictive cues)11,54, other projections and circuit
specializations more speciﬁcally convey information about energetic needs19,25,57. An additional level of complexity is likely
overlaid upon these distinct afferent pathways, namely statedependent modulation of neuronal activity in the PVT. For
example, orexinergic input to the PVT may carry arousal-related
signals that invigorate reward-seeking behavior12,58. In contrast,
inputs relaying information about threatening situations may
dampen PVT responding to reward-related cues resulting in
diminished food seeking43,59,60. This view is supported by recent
studies suggesting that the PVT is required amid motivational
conﬂicts for the integration of reward- and aversive-related guiding
behavior42,43.
While conceptual models of the function of the VLM are far
from complete, decades of research have identiﬁed the existence
of distinct VLMCA neuronal subgroups that are differentially
activated by glucoprivation. Thus, while mild glucoprivation is
known to drive hyperglycemia via the activation of spinally
projecting VLMCA neurons, feeding behavior is selectively
induced under intense glucoprivation61 and requires the activity
of forebrain-projecting VLMCA neurons3. A major forebrain
8

target of these VLMCA neurons, the PVT, is thought to participate in driving food-seeking behavior. But most models assume
that the PVT integrates metabolic signals arising exclusively from
the hypothalamus13. In addition, a recent study demonstrated
that PVT neurons are equipped with intrinsic mechanisms that
may facilitate food seeking in response to decreases in extracellular glucose19. Whereas the biologically relevant circumstances that lead to direct recruitment of the PVT by this
mechanism are not fully understood, our study expands the role
of the PVT in metabolic regulation, by showing that, under
extreme circumstances, metabolic information can be directly
communicated to it by hindbrain catecholaminergic cells. As
such, in addition to the intrinsic glucose-sensing mechanisms of
PVT neurons, the existence of parallel hypothalamus–PVT and
VLMCA–pPVT circuits may constitute fail-safe mechanisms that
ensure appropriate adaptation to metabolic status. Future studies
should aim deﬁne the precise circuit and cellular mechanisms by
which the pPVT–NAc pathway coordinates reward-related
behaviors.
Methods
Mice. All procedures were approved by the National Institute of Mental Health
Animal Care and Use Committees performed following the Guide for the Care and
Use of Laboratory Animals. For all experiments, both male and female (7–12 weeks
of age), TH-IRES-Cre mice (European Mouse Mutant Archive; stock number:
EM:00254; backcrossed ﬁve generations with C57Bl/6NJ mice) and C57BL/6NJ
strain mice (The Jackson Laboratory) were used in this study. Mice were housed
under a 12-h light–dark cycle (6 a.m. to 6 p.m. light) at temperature of 70–74 °F
and 40–65% humidity, with food and water available ad libitum. Animals were
randomly allocated to the different experimental conditions reported in this study.
Viral vectors. AAV2/5-Ef1a-DIO hChR2(E123T/T159C)-EYFP and AAV9-hSynFLEX-GCaMP6s-WPRE-SV40 were produced by the Vector Core of the University
of Pennsylvania. AAV9-EF1a-DIO-eNpHR3.0-mCherry, AA9-CAG-FLEX-tdTomato, AV9-hSyn-DIO-mCherry-2A-SyneGFP and AAV2-Syn-DIO-GFP were
produced by the Vector Core of the University of North Carolina. AAV5-SynFLEX-ChrimsonR-tdTomato (Addgene plasmid # 62723) and AAV2-hSyn-DIOhM4Di-mCherry, AAV2-hSyn-DIO-hM3D(Gq)-mCherry were produced by
Addgene. AAV2(retro)-CAG-iCre (Addgene plasmid # 81070) was produced by
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Fig. 7 The VLMCA–pPVT pathway is necessary for glucoprivation-induced feeding behavior. a Schematic of the stereotaxic injections for selective
expression of halorhodopsin (eNpHR) and control viral vectors in VLMCA neurons using of TH-IRES-Cre mice, as well as optical ﬁber implantation for
optogenetic inhibition of VLMCA projections to the pPVT. b Representative image of eNpHR-mCherry expression in the VLM (left) of TH-IRES-Cre mice
and eNpHR-mCherry terminals in the pPVT (right). c Quantiﬁcation of food intake 2 h after 2DG administration. TH-IRES-Cre mice expressing eNpHR or
control virus were injected with 2DG and immediately subjected to photoinhibition of VLMCA–pPVT terminals for the ﬁrst hour of the 2 hr test (light on).
VLMCA–pPVT inhibition suppressed 2DG induced increases in feeding behavior. Total food intake in grams, Control, 0.36 ± 0.04, n = 8 mice; eNpHR, 0.17
± 0.05, n = 9 mice; two-sided Unpaired t-test, *P = 0.018. d Quantiﬁcation of blood glucose levels after 2DG administration in TH-IRES-Cre mice
expressing either eNpHR or a control virus in VLMCA neurons. VLMCA–pPVT inhibition had no effect on 2DG-mediated adrenal medullary hyperglycemia.
Glucose levels in mg/dL, Control, 300 ± 22.78, n = 10 mice; eNpHR, 284.29 ± 13.93, n = 7 mice; two-sided Unpaired t-test, P = 0.61. e Quantiﬁcation of
blood CORT levels after 2DG administration in TH-IRES-Cre mice expressing either eNpHR or a control virus in VLMCA neurons. VLMCA–pPVT inhibition
had no effect on 2DG increases in corticosterone secretion. CORT levels in mg/dL, Control, 457.90 ± 154.55, n = 4 mice; eNpHR, 451.10 ± 29.62, n = 7
mice; two-sided Unpaired t-test, P = 0.96. f Quantiﬁcation of food intake for 2 h immediately after overnight food restriction. TH-IRES-Cre mice expressing
either eNpHR or a control virus were food restricted overnight and then immediately given access to food while subjected to photoinhibition of
VLMCA–pPVT synapses. VLMCA–pPVT inhibition had no effect on feeding behavior after overnight food restriction, in the absence of 2DG. Total food
intake in grams, Control, 0.79 ± 0.12, n = 6 mice; eNpHR, 0.68 ± 0.15, n = 6 mice; two-sided Unpaired t-test, P = 0.60. Box chart legend: box is deﬁned by
25th, 75th percentiles, whiskers are determined by 5th and 95th percentiles, and mean is depicted by the square symbol. Data presented as mean ± SEM.
Vector Biolabs. AAV9-EF1a-FLEX-TVA-mCherry (Addgene plasmid # 38044) and
AAV9-CAG-FLEX-RG (Addgene plasmid # 38043) were produced by Vigene
Biosciences, Inc. EnvA-SAD-ΔG-eGFP (Addgene plasmid # 32635) was produced
by the Viral Vector Core of the Salk Institute for Biological Studies. AAV2-retroCAG-tdTomato-WPRE is a gift from Dr. Yuanyuan Liu at NIDCR. All viral vectors
were stored in aliquots at −80°C until use.
Drugs. 2-Deoxy-D-glucose (Tocris catalog# 4515) was used at a 500 mg/Kg dose.
CNO (Enzo Life Sciences, catalog# BML-NS105) was used at a 10 mg/Kg dose
when used in combination with the inhibitory DREADDs virus and a dose of 0.75
mg/Kg in combination with the excitatory DREADDs virus. Propranolol hydrochloride (Tocris catalog# 0624) at a concentration of 30 µM was used to block beta
adrenergic receptors in acute brain slices.
Antibodies. The primary antibodies: anti-cFos (1:1000, rabbit polyclonal, Millipore, catalog# ABE457; 1:50, rabbit monoclonal, Cell Signaling, catalog# 2250),
validated for application (ABE457 and 2250) and specie (2250); and anti-TH
(1:1000, chicken polyclonal, Aves Labs, catalog# AB_10013440), validated for
application and specie. Fluorophore-conjugated secondary antibodies (conjugated
with goat anti-rabbit Alexa Fluor-488 (A-11008) and goat anti-chicken Alexa
Fluor-647 (A-21449)) were purchased from ThermoFisher Scientiﬁc and used at a
1:500 dilution. Antibodies were diluted in PBS with 10% NGS and PBST. For

additional information on the validation of the antibodies used, please visit the
manufacturer’s website.

Stereotaxic surgery. All stereotaxic surgeries were conducted as described in our
animal study protocol. Mice were ﬁrst anesthetized with a Ketamine/Xylazine
solution and an AngleTwo stereotaxic device (Leica Biosystems) was used for viral
injections at the following stereotaxic coordinates: pPVT, −1.60 mm from Bregma,
0.06 mm lateral from midline, and −3.30 mm vertical from cortical surface (at a 6°
angle) NAc, 1.70 mm from Bregma, 0.60 mm lateral from midline, and −4.54 mm
vertical from cortical surface; VLM, −7.30 mm from Bregma, 1.40 mm lateral from
midline, and −5.30 mm vertical from cortical surface. AAVs were injected at a total
volume of 0.1–0.15 μl in the VLM. All other AAVs were injected at approximately
1–1.5 μl. Following stereotaxic injections, AAVs were allowed 2–3 weeks for
maximal expression. Optical ﬁbers with diameters of 200 μm (0.48 NA) and
400 μm (0.66 NA) were used for optogenetics and ﬁber photometry experiments,
respectively (Doric Lenses). These ﬁbers were implanted over the pPVT immediately after viral injections (coordinate: –1.60 mm from Bregma, 0.06 mm lateral
from midline, and −2.90 mm vertical from cortical surface) and cemented using
C&B Metabond Quick Adhesive Cement System (Parkell, Inc.) and Jet Brand
dental acrylic (Lang Dental Manufacturing Co., Inc.). Mice received subcutaneous
injections with metacam (meloxicam, 1–2 mg/kg) for analgesia and anti-
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Fig. 8 pPVT–NAc neuron activity is required for glucoprivation-induced feeding behavior. a Schematic of the stereotaxic injections for selective
expression of the hM4Di-mCherry and control viral vectors in pPVT–NAc neurons. b Representative image of hM4Di-mCherry expression in pPVT–NAc
neurons. c Quantiﬁcation of food intake for a 5-h period after 2DG administration. Mice expressing either hM4Di or the control virus in pPVT–NAc neurons
were injected with either saline or CNO, 30 min prior to 2DG administration. pPVT–Nac neurons inhibition suppressed the 2DG-induced increases in
feeding behavior. Total food intake in grams, tdT_Saline, 0.72 ± 0.07, n = 6 mice; tdT_CNO, 0.70 ± 0.08, n = 6 mice; hM4Di_Saline, 0.73 ± 0.07, n = 8
mice; hM4Di_CNO, 0.36 ± 0.09, n = 8 mice; effect of treatments, F(1,24) = 4.35, P < 0.05; effect of virus, F(1,24) = 3.05, P > 0.05; interaction, F(1,24) =
3.78, P > 0.05, two-way analysis of variance (ANOVA) followed by Tukey’s test. Group comparisons: tdT_Saline vs tdT_CNO, P = 0.99, tdT_Saline vs
hM4Di_Saline, P = 1.00, tdT_Saline vs hM4Di_CNO, P = 0.06, tdT_CNO vs hM4Di_CNO, P = 0.07; hM4Di_Saline vs hM4Di_CNO, *P = 0.02. Data from
Supplementary Fig. 8 included for comparison purposes (shaded portion of the graph). Box chart legend: box is deﬁned by 25th, 75th percentiles, whiskers
are determined by 5th and 95th percentiles, and mean is depicted by the square symbol. Data presented as mean ± SEM.
inﬂammatory purposes postoperatively and were allowed to recover on a heating
pad where they were constantly monitored.
Histology. Mice were injected with euthanasia solution and subsequently sacriﬁced
via transcardial perfusion, ﬁrst with PBS and then with paraformaldehyde (PFA;
4% in PBS). Brains were then postﬁxed in 4% PFA at 4 °C overnight, and cryoprotected using a 30% PBS-buffered sucrose solution for ~24–36 h. Coronal brain
sections (45 μm) were acquired using a freezing microtome (SM 2010R, Leica). For
immunostainings, brain sections were blocked in 10% normal goat serum (NGS) in
PBST (0.1% Triton X-100 in PBS) for 1 h at RT, followed by incubation with
primary antibodies in 10% NGS-PBST for 48 h at 4 °C. Sections were then washed
with PBST (3 × 15 min) and incubated with ﬂuorescent secondary antibodies at RT
for 1 h in 10% NGS-PBST. Sections were washed in PBS (3 × 15 min), mounted
onto glass slides and coverslipped with ProLong Diamond antifade (ThermoFisher
Scientiﬁc). Images were taken using a Carl Zeiss LSM 780 confocal microscope
using ZEN (version 2.3, Carl Zeiss Microscopy, LLC). Image analysis and cell
counting were performed using ImageJ software by a blinded experimenter (Fiji,
version 2017 May 30). Optical ﬁber placements for all subjects included in this
study are presented in Supplementary Fig. 11.
Monosynaptic tracing with pseudotyped rabies virus. To trace monosynaptic
inputs onto NAc-projecting neurons of the PVT we used the pseudotyped rabies
virus20. Brieﬂy, to limit monosynaptic rabies tracing to NAc-projecting neurons of
the PVT, we ﬁrst injected ~1 µl of the AAV2(retro)-CAG-iCre bilaterally into the
NAc of C57BL/6NJ mice. Next, during the same surgical procedure, a virus mixture
containing AAV9-EF1a-FLEX-TVA-mCherry and AAV9-CAG-FLEX-RG at a 1:1
ratio was injected into the pPVT (total volume ~1.5 ul), to enable expression of the
following components in a Cre-dependent manner: a red ﬂuorescent reporter,
mCherry; an avian receptor, termed TVA; and the rabies envelope glycoprotein
(G). Two weeks later mice were injected in the same pPVT location with the
pseudotyped rabies virus EnvA-SAD-ΔG-eGFP (1.5 μl). Pseudotyping consisted in
replacing the envelope glycoprotein G of the rabies virus with an avian envelope
termed EnvA. This G-deﬁcient rabies virus can only infect cells that express the
TVA receptor, thereby conferring genetic speciﬁcity to the method. Importantly,
complementation of the pseudotyped rabies virus with envelope glycoprotein in the
TVA-expressing cells as described above allows the generation of infectious particles, which in turn can trans-synaptically spread to presynaptic neurons. One
week after pseduotyped rabies injection, brain tissues were collected and subjected
to analysis.
Electrophysiology. For electrophysiological experiments, mice were anesthetized
with isoﬂurane, decapitated, and their brains quickly removed and chilled in icecold dissection buffer (110.0 mM choline chloride, 25.0 mM NaHCO3, 1.25 mM
NaH2PO4, 2.5 mM KCl, 0.5 mM CaCl2, 7.0 mM MgCl2, 25.0 mM glucose, 11.6 mM
ascorbic acid, and 3.1 mM pyruvic acid, gassed with 95% O2 and 5% CO2). Coronal
sections (300 μm thick) containing the pPVT were cut in dissection buffer using a
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VT1200S automated vibrating-blade microtome (Leica Biosystems), and were
subsequently transferred to incubation chamber containing artiﬁcial cerebrospinal
ﬂuid (ACSF) (118 mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO3, 1 mM NaH2PO4,
20 mM glucose, 2 mM MgCl2, and 2 mM CaCl2, at 34 °C, pH 7.4, gassed with 95%
O2 and 5% CO2). After at least 40 min recovery time, slices were transferred to
room temperature (20–24 °C) and were constantly perfused with ACSF.
Whole-cell patch-clamp recordings from pPVT neurons were obtained with
Multiclamp 700B ampliﬁers (Molecular Devices), under visual guidance with an
Olympus BX51 microscope with transmitted light illumination. Current clamp
recordings were made with an internal solution containing: 130 mM K-Gluconate,
5 mM KCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2AP, 0.4 mM Na3GTP, 10
mM Na-phosphocreatine, and 0.6 mM EGTA (pH 7.2). Recorded signals were lowpass ﬁltered at 1 kHz and acquired at a sampling rate of 10 kHz using pCLAMP 10
(Molecular Devices). For patch-clamp recordings of VLMCA-mediated responses in
pPVT neurons, ﬁrst ChR2 was expressed in the VLM of TH-Cre mice following the
above described methods. Optogenetic stimulation was done using an LED
illuminator (pE-300 white; CoolLED, Ltd.) directly connected to the
epiﬂuorescence port of the Olympus BX51 microscope. Blue light pulses 1 ms long
where delivered at 20 Hz for a duration of 5 s. Data from patch-clamp whole-cell
recordings were analyzed using Calmpﬁt (pCLAMP10 suite, Molecular Devices).

Bulk Ca2+ and ﬁber photometry. The ﬁber photometry procedure for calcium
measurements were conducted as follows51. Brieﬂy, we used a custom-ordered ﬁber
photometry Mini Cube (Doric Lenses) equipped with three excitation and two
emission ports. Speciﬁcally, the system is integrated with two continuous sinusoidally modulated LED (DC4100, ThorLabs) at 473 nm (211 Hz) and 405 nm
(531 Hz) that served as light source to excite GCaMP6s and an isosbestic autoﬂuorescence signal, respectively. Optogenetic manipulations were allowed via a
third excitation port (555–570 nm). Fluorescence signals were collected by the
same ﬁber implant that was coupled to a 400 μm optical patch-cord (0.48 NA) and
focused onto two separate photoreceivers (2151, Newport Corporation) connected
to the emission ports of the Mini Cube. An RZ5P acquisition system (Tucker-Davis
Technologies; TDT), equipped with a real-time signal processor and controlled by
a software interface (Synapse version 92) was used to control the LEDs and also to
independently demodulate the ﬂuorescence signal due to 473 nm and 405 nm
excitation. The LED intensity (ranging 10–15 μW) at the interface between the ﬁber
tip and the animal was constant throughout the session. All photometry experiments were performed in behavioral chambers (Coulbourn Instruments) and video
recorded using video cameras installed above each behavioral chamber. TTL pulses
recorded by the same system were used to annotate the occurrence of behavioral
manipulations. For ΔF/F analysis, a least-squares linear ﬁt to the 405 nm signal to
align it to the 470 nm signal was ﬁrst applied. The resulting ﬁtted 405 nm signal
was then used to normalize the 473 nm as follows: ΔF/F = (473 nm signal − ﬁtted
405 nm signal)/ﬁtted 405 nm signal. Lastly, changes in ﬂuorescence after stimulation or after feeding were determined by the area under the ΔF/F curve, before and
after stimulus.
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Optogenetics and behavioral protocols
Feeding behavior. TH-IRES-Cre mice injected with either Cre-dependent ChR2 or
Cre-dependent tdTomato (control) in the VLM and an optical ﬁber placed above
the pPVT were behaviorally tested 3 weeks later. First, mice were tethered with an
optical patch cord and placed in an open-ﬁeld box (45 × 45 × 40 cm) where they
were given access to 20 mg food pellets for 30 min (Pre-test). Immediately after the
pre-test, mice received light stimulation with a blue laser tuned at 473 nm at a
frequency of 20 Hz (10 ms width) for 30 min using a 1 min “ON” 2 min “OFF”
protocol. The stimulation protocol used was based on preliminary studies showing
constant stimulation produced signiﬁcant decreases in locomotion (described in
the main text). After light stimulation, mice were given another 30 min with access
to food (Post-test). For Th-IRES-Cre mice that expressed ChrimsonR virus in lieu
of ChR2, a yellow laser tuned at 561 nm, but the stimulation protocol was identical
to the one used for ChR2 expressing mice. In addition, for these mice, the duration,
quantity, and timing of feeding epochs were quantiﬁed using a custom designed
feeding experimentation device (FED3) (provided by Alexxai Kravitz). For assessing 2DG-evoked feeding and using halorhodopsin (eNpHR), light stimulation was
achieved using a yellow laser (561 nm) delivered in 5 s ‘light ON’ / 5 s ‘light OFF’
intervals for 1 hr. This photoinhibition protocol was used to avoid off-target
inﬂuences of prolonged optogenetic activation (i.e., rebound excitation). The power
of both the blue and yellow lasers for all experiments was 5–10 mW, measured at
tip of the patch chord.
Foraging decision task. The foraging track consisted of an elevated long linear
chamber (150 × 32 × 25, L × W × H in cm) that was divided into 3 zones: trigger
zone, corridor, and reward zone. The ends of the track were designated as the
trigger zone and reward zone, while the center served as the corridor. This task
consisted of 60 min sessions of self-paced trials. For each trial, food restricted (85%
FFW) mice were trained to wait in the trigger zone for an auditory cue that
signaled reward availability. Mice were then required to run from the trigger zone
to the reward zone to retrieve a food reward (strawberry Ensure). Lastly, mice
returned to the trigger zone to initiate another trial. The movement of the mice was
tracked with an overhead camera and by digital distance sensors 15 cm (Pololu
Robotics and Electronics) located throughout the track and at the entrance of the
reward, trigger zone, and food port. Video tracking was performed using Ethovision XT 12 (Noldus) software. Strawberry Ensure solution was delivered through a
liquid dispenser (Med-associates Inc.) localized at the end wall of reward zone, 2
cm above the ﬂoor of track. Experimental schedule and data acquisition were
implemented through the Abet II software for operant control (Lafayette Instruments Neuroscience) and through the Whisker multimedia software (Lafayette
Instruments Neuroscience).
Real-time place aversion (RTPA). TH-IRES-Cre mice expressing ChR2 or control
virus in the VLM and implanted with an optical ﬁber in the pPVT were ﬁrst
handled for at least 3 consecutive days. Mice were connected to the ﬁber patchcord, then tested for place aversion using a real-time place aversion paradigm. First,
mice were allowed to explore a shuttle box containing two adjacent (50 cm×30 cm)
chambers for 10 mins to establish a side preference. Thereafter, one side was
chosen randomly for optical stimulation, such that constant blue light at a frequency of 20 Hz (10 ms width) and a power of 5–10 mW was delivered upon entry
of the preferred chamber. The cumulative time spent in different areas of the
shuttle box during baseline and stimulation was tracked, recorded, and quantiﬁed
using ANY-maze (version 5) behavioral tracking software.

subjected to optogenetic silencing of the VLMCA–pPVT pathway using eNpHR
and a photoinhibition protocol identical as those used for the 2DG experiments
(light delivered using 5 s ‘light ON’ / 5 s ‘light OFF’ intervals for 1 hr; 5–10 mW
power). One hour after 2DG injection and optogenetic silencing, blood samples
were collected via a small incision in the tip of the subject’s tail and blood glucose
levels were measured using a Care Touch Diabetes Testing Kit. Immediately after,
additional blood samples were collected into a heparinized SafeCrit plastic tube
(Tris Sample Processing). Serum was gathered after and centrifuged using a
CritSpin® Micro-Hematocrit Centrifuge for 2 min. Corticosterone protein levels
from serum were determined using a DetectX® CORTICOSTERONE Enzyme
Immunoassay Kit (Arbor Assays) by following manufacturer’s protocol. Brieﬂy,
serum was dissociated with dissociation reagent for 10 min at room temperature,
and then diluted in buffer 1:100. Standards and samples were added into 96-well
microplates and followed by adding DetectX® corticosterone conjugate as well as
DetectX® conticosterone antibody. After 2 h incubation, wells were washed four
times with 300 μl washer buffer. A TMB substrate solution was added into the wells
for an additional 30-min incubation without shaking and yielded a blue color,
which turned to yellowish when the Stop Solution was added. The optical density
of each well was detected using a microplate reader set at 450 nm, and the plate
reader’s built-in 4PLC software calculated corticosterone concentration for
each well.
Statistics and data presentation. All data were analyzed using Origin Pro 2016
(OriginLab Corp). All statistical tests are indicated when used. No assumptions or
corrections were made prior to data analysis. All data are presented as mean ± s.e.
m. All cell counting experiments and behavioral testing were performed by an
experimenter blind to the experimental condition. The sample sizes used in our
study, such as the numbers of neurons or animals, are typically the same or exceed
those estimated by power analysis (power = 0.80, α = 0.05). For electrophysiological analyses, the sample size is 8–15 cells. For optogenetic-only feeding
experiments, the sample size is 6–12 mice. For combined optogenetic and ﬁber
photometry experiments, the sample size is 5–9 mice. For ﬁber photometry
experiment in the reward foraging task, the sample size is 5 mice. For optogenetic
experiments used to assess aversive and anxiety-like behavior, the sample size is
5–12 mice. For glucose and CORT assays, the sample size was 4–10 mice. For
immunohistochemical cFos analyses, the sample size is 3–6 mice. All experiments
were replicated at least once.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All the data that support the ﬁndings presented in this study are available from the
corresponding author upon reasonable request. Source data are provided with this paper.
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